Get access

Neutrophils, interleukin-17 and obstructive airway disease


Associate Professor Anders Lindén, Lung Pharmacology Group, Department of Respiratory Medicine & Allergology, Institute of Internal Medicine, Göteborg University, Guldhedsgatan 10A, SE-413 46 Gothenburg, Sweden. Email:


There is increasing evidence that an exaggerated accumulation of activated neutrophils is linked to the clinical course of obstructive airway diseases, such as asthma and chronic obstructive pulmonary disease. The present review article focuses on the evidence that the T cell cytokine interleukin (IL)-17 plays a role in orchestrating the accumulation and subsequent activation of neutrophils in the airways and lungs. The mechanistic roles of neutrophils and IL-17 in obstructive airway disease are discussed. It is concluded that targeting IL-17 may consitute a potential strategy for developing novel pharmacotherapeutic interventions against obstructive airway disease.

Get access to the full text of this article